HOUSTON, Jan. 26, 2017 -- Marathon Oil Corporation (NYSE: MRO) announced today it plans to issue its fourth quarter and full-year 2016 earnings news release and details of the Company’s 2017 capital program on Wednesday, Feb. 15, after the close of U.S. financial markets.
Prepared remarks along with accompanying slides will be available on the Company's website approximately one hour after the earnings news release is issued. The Company will conduct a conference call, which will be webcast live, on Thursday, Feb. 16, at 10 a.m. ET.
Zach Dailey, director of Investor Relations, will host the call. Also participating from Marathon Oil will be Lee Tillman, president and CEO; Mitch Little, executive vice president, Operations; and Pat Wagner, interim CFO and vice president, Corporate Development and Strategy. The call will include forward-looking information.
All of the above information can be accessed by visiting Marathon Oil's website at http://www.MarathonOil.com. Additional financial information, including earnings releases and other investor-related material, is available online and on Marathon Oil's app for mobile devices.
Media Relations Contacts:
Lee Warren: 713-296-4103
Investor Relations Contact:
Zach Dailey: 713-296-4140


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



